Nationwide Fund Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-70,059
| Closed | -$2.87M | – | 2590 |
|
|
2017
Q3 | $2.87M | Buy |
70,059
+4,208
| +6% | +$172K | 0.01% | 1289 |
|
|
2017
Q2 | $1.98M | Buy |
65,851
+6,451
| +11% | +$194K | 0.01% | 1432 |
|
|
2017
Q1 | $2.15M | Buy |
59,400
+1,771
| +3% | +$64K | 0.01% | 1360 |
|
|
2016
Q4 | $2.89M | Buy |
57,629
+3,547
| +7% | +$178K | 0.01% | 1245 |
|
|
2016
Q3 | $2.84M | Buy |
54,082
+3,472
| +7% | +$182K | 0.01% | 1239 |
|
|
2016
Q2 | $2.09M | Buy |
50,610
+6,560
| +15% | +$271K | 0.01% | 1336 |
|
|
2016
Q1 | $1.79M | Sell |
44,050
-676
| -2% | -$27.5K | 0.01% | 1401 |
|
|
2015
Q4 | $1.86M | Sell |
44,726
-2,533
| -5% | -$105K | 0.01% | 1395 |
|
|
2015
Q3 | $727K | Sell |
47,259
-760
| -2% | -$11.7K | ﹤0.01% | 1896 |
|
|
2015
Q2 | $1.19M | Buy |
48,019
+1,821
| +4% | +$45.2K | ﹤0.01% | 1758 |
|
|
2015
Q1 | $1.06M | Buy |
46,198
+11,812
| +34% | +$270K | ﹤0.01% | 1854 |
|
|
2014
Q4 | $928K | Sell |
34,386
-2,160
| -6% | -$58.3K | ﹤0.01% | 1849 |
|
|
2014
Q3 | $429K | Buy |
36,546
+2,650
| +8% | +$31.1K | ﹤0.01% | 2296 |
|
|
2014
Q2 | $527K | Buy |
33,896
+7,930
| +31% | +$123K | ﹤0.01% | 2232 |
|
|
2014
Q1 | $510K | Buy |
25,966
+21,763
| +518% | +$427K | ﹤0.01% | 2056 |
|
|
2013
Q4 | $71K | Buy |
+4,203
| New | +$71K | ﹤0.01% | 3029 |
|